Structure

Physi-Chem Properties

Molecular Weight:  396.18
Volume:  382.663
LogP:  0.083
LogD:  0.08
LogS:  -2.979
# Rotatable Bonds:  1
TPSA:  141.36
# H-Bond Aceptor:  8
# H-Bond Donor:  4
# Rings:  4
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.329
Synthetic Accessibility Score:  5.385
Fsp3:  0.85
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.587
MDCK Permeability:  0.00010987859423039481
Pgp-inhibitor:  0.555
Pgp-substrate:  0.862
Human Intestinal Absorption (HIA):  0.75
20% Bioavailability (F20%):  0.021
30% Bioavailability (F30%):  0.67

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.317
Plasma Protein Binding (PPB):  23.668926239013672%
Volume Distribution (VD):  0.353
Pgp-substrate:  64.44719696044922%

ADMET: Metabolism

CYP1A2-inhibitor:  0.009
CYP1A2-substrate:  0.168
CYP2C19-inhibitor:  0.009
CYP2C19-substrate:  0.686
CYP2C9-inhibitor:  0.001
CYP2C9-substrate:  0.093
CYP2D6-inhibitor:  0.002
CYP2D6-substrate:  0.111
CYP3A4-inhibitor:  0.011
CYP3A4-substrate:  0.134

ADMET: Excretion

Clearance (CL):  3.611
Half-life (T1/2):  0.451

ADMET: Toxicity

hERG Blockers:  0.047
Human Hepatotoxicity (H-HT):  0.228
Drug-inuced Liver Injury (DILI):  0.307
AMES Toxicity:  0.026
Rat Oral Acute Toxicity:  0.232
Maximum Recommended Daily Dose:  0.017
Skin Sensitization:  0.088
Carcinogencity:  0.039
Eye Corrosion:  0.004
Eye Irritation:  0.014
Respiratory Toxicity:  0.26

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC293850

Natural Product ID:  NPC293850
Common Name*:   AFJYIZMCHVBLPP-YREBFMARSA-N
IUPAC Name:   n.a.
Synonyms:   Rel-Yadanziolide T
Standard InCHIKey:  AFJYIZMCHVBLPP-YREBFMARSA-N
Standard InCHI:  InChI=1S/C20H28O8/c1-7-4-10(22)17(26)19(2)9(7)5-11-20(3)12(14(24)18(27)28-11)8(6-21)13(23)15(25)16(19)20/h4,8-9,11-17,21,23-26H,5-6H2,1-3H3/t8-,9+,11-,12-,13-,14-,15+,16-,17-,19+,20+/m1/s1
SMILES:  OC[C@H]1[C@@H](O)[C@H](O)[C@H]2[C@@]3([C@H]1[C@@H](O)C(=O)O[C@@H]3C[C@@H]1[C@]2(C)[C@H](O)C(=O)C=C1C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1923102
PubChem CID:   56833962
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001283] Terpene lactones
          • [CHEMONTID:0002119] Quassinoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO15436 Brucea mollis Species Simaroubaceae Eukaryota n.a. stem n.a. PMID[22070654]
NPO15436 Brucea mollis Species Simaroubaceae Eukaryota stems n.a. n.a. PMID[22070654]
NPO15436 Brucea mollis Species Simaroubaceae Eukaryota n.a. stem n.a. PMID[24199564]
NPO15436 Brucea mollis Species Simaroubaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT180 Cell Line HCT-8 Homo sapiens IC50 = 3360.0 nM PMID[523111]
NPT181 Cell Line Bel-7402 Homo sapiens IC50 = 4400.0 nM PMID[523111]
NPT81 Cell Line A549 Homo sapiens IC50 > 10000.0 nM PMID[523111]
NPT179 Cell Line A2780 Homo sapiens IC50 > 10000.0 nM PMID[523111]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 3000.0 nM PMID[523111]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC293850 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9612 High Similarity NPC11252
0.9612 High Similarity NPC289312
0.9519 High Similarity NPC208998
0.9519 High Similarity NPC7921
0.9519 High Similarity NPC49451
0.9515 High Similarity NPC201992
0.9429 High Similarity NPC18547
0.9429 High Similarity NPC474906
0.934 High Similarity NPC235539
0.934 High Similarity NPC328374
0.934 High Similarity NPC96312
0.934 High Similarity NPC134869
0.934 High Similarity NPC40632
0.934 High Similarity NPC152199
0.934 High Similarity NPC251236
0.9333 High Similarity NPC51978
0.9327 High Similarity NPC171888
0.9327 High Similarity NPC146945
0.9314 High Similarity NPC144854
0.9314 High Similarity NPC3316
0.9252 High Similarity NPC470854
0.9252 High Similarity NPC474654
0.9252 High Similarity NPC309433
0.9252 High Similarity NPC287343
0.9252 High Similarity NPC97908
0.9252 High Similarity NPC122033
0.9245 High Similarity NPC473798
0.9238 High Similarity NPC474516
0.9223 High Similarity NPC192813
0.9223 High Similarity NPC154608
0.9223 High Similarity NPC277017
0.9167 High Similarity NPC204552
0.9167 High Similarity NPC17772
0.9167 High Similarity NPC251310
0.9167 High Similarity NPC188667
0.9167 High Similarity NPC297179
0.9083 High Similarity NPC475775
0.9083 High Similarity NPC476529
0.9057 High Similarity NPC302146
0.9029 High Similarity NPC102352
0.902 High Similarity NPC275583
0.9 High Similarity NPC107338
0.9 High Similarity NPC112038
0.9 High Similarity NPC109607
0.8972 High Similarity NPC194100
0.8952 High Similarity NPC27814
0.8919 High Similarity NPC102822
0.8919 High Similarity NPC477046
0.8911 High Similarity NPC472972
0.8909 High Similarity NPC469488
0.8909 High Similarity NPC470777
0.8889 High Similarity NPC469877
0.8889 High Similarity NPC470919
0.8868 High Similarity NPC210005
0.8846 High Similarity NPC181357
0.8807 High Similarity NPC207217
0.8807 High Similarity NPC470628
0.8807 High Similarity NPC474046
0.8807 High Similarity NPC474734
0.8807 High Similarity NPC259306
0.8774 High Similarity NPC141350
0.8774 High Similarity NPC143706
0.8774 High Similarity NPC310546
0.8774 High Similarity NPC472534
0.875 High Similarity NPC475036
0.875 High Similarity NPC65523
0.8727 High Similarity NPC473968
0.8727 High Similarity NPC473590
0.8727 High Similarity NPC176513
0.8727 High Similarity NPC470775
0.8716 High Similarity NPC102088
0.8716 High Similarity NPC243354
0.8716 High Similarity NPC268238
0.8716 High Similarity NPC143268
0.8716 High Similarity NPC323821
0.8716 High Similarity NPC45218
0.8704 High Similarity NPC90769
0.8684 High Similarity NPC24651
0.8684 High Similarity NPC470922
0.8673 High Similarity NPC312833
0.8649 High Similarity NPC470776
0.8636 High Similarity NPC173686
0.8636 High Similarity NPC16081
0.8624 High Similarity NPC62696
0.8624 High Similarity NPC293038
0.8624 High Similarity NPC194273
0.8611 High Similarity NPC471243
0.8596 High Similarity NPC265557
0.8596 High Similarity NPC67251
0.8596 High Similarity NPC105926
0.8596 High Similarity NPC18945
0.8596 High Similarity NPC91693
0.8585 High Similarity NPC230541
0.8585 High Similarity NPC202524
0.8571 High Similarity NPC127530
0.8571 High Similarity NPC473401
0.8545 High Similarity NPC475633
0.8532 High Similarity NPC471967
0.8532 High Similarity NPC472002
0.8532 High Similarity NPC280782
0.8522 High Similarity NPC476729
0.8522 High Similarity NPC473255
0.8509 High Similarity NPC471965
0.8505 High Similarity NPC94942
0.8505 High Similarity NPC272576
0.8491 Intermediate Similarity NPC477877
0.8468 Intermediate Similarity NPC179626
0.8462 Intermediate Similarity NPC476132
0.8455 Intermediate Similarity NPC255017
0.8455 Intermediate Similarity NPC320118
0.8455 Intermediate Similarity NPC198539
0.844 Intermediate Similarity NPC188738
0.844 Intermediate Similarity NPC34315
0.8435 Intermediate Similarity NPC14617
0.8435 Intermediate Similarity NPC262199
0.8435 Intermediate Similarity NPC202666
0.8435 Intermediate Similarity NPC471961
0.8435 Intermediate Similarity NPC471964
0.8426 Intermediate Similarity NPC41405
0.8421 Intermediate Similarity NPC275675
0.8421 Intermediate Similarity NPC470779
0.8407 Intermediate Similarity NPC77689
0.8407 Intermediate Similarity NPC473636
0.8393 Intermediate Similarity NPC134430
0.8378 Intermediate Similarity NPC178289
0.8376 Intermediate Similarity NPC470882
0.8365 Intermediate Similarity NPC476195
0.8364 Intermediate Similarity NPC116794
0.8364 Intermediate Similarity NPC234042
0.8364 Intermediate Similarity NPC152117
0.8362 Intermediate Similarity NPC471963
0.8362 Intermediate Similarity NPC247315
0.8362 Intermediate Similarity NPC471962
0.8349 Intermediate Similarity NPC68419
0.8349 Intermediate Similarity NPC102914
0.8349 Intermediate Similarity NPC7870
0.8349 Intermediate Similarity NPC220984
0.8349 Intermediate Similarity NPC108709
0.8349 Intermediate Similarity NPC110139
0.8349 Intermediate Similarity NPC75747
0.8349 Intermediate Similarity NPC274507
0.8349 Intermediate Similarity NPC199457
0.8348 Intermediate Similarity NPC222688
0.8333 Intermediate Similarity NPC471406
0.8333 Intermediate Similarity NPC476479
0.8333 Intermediate Similarity NPC477437
0.8333 Intermediate Similarity NPC477438
0.8333 Intermediate Similarity NPC94529
0.8319 Intermediate Similarity NPC286347
0.8317 Intermediate Similarity NPC477436
0.8317 Intermediate Similarity NPC477435
0.8302 Intermediate Similarity NPC282233
0.8302 Intermediate Similarity NPC95585
0.8302 Intermediate Similarity NPC264048
0.8291 Intermediate Similarity NPC285091
0.8288 Intermediate Similarity NPC962
0.8288 Intermediate Similarity NPC471204
0.8288 Intermediate Similarity NPC477266
0.8288 Intermediate Similarity NPC250109
0.8288 Intermediate Similarity NPC271138
0.8288 Intermediate Similarity NPC269315
0.8276 Intermediate Similarity NPC227397
0.8273 Intermediate Similarity NPC250481
0.8273 Intermediate Similarity NPC297208
0.8273 Intermediate Similarity NPC213320
0.8273 Intermediate Similarity NPC179434
0.8273 Intermediate Similarity NPC108748
0.8273 Intermediate Similarity NPC30397
0.8273 Intermediate Similarity NPC263827
0.8273 Intermediate Similarity NPC211798
0.8273 Intermediate Similarity NPC191763
0.8273 Intermediate Similarity NPC473481
0.8273 Intermediate Similarity NPC235841
0.8273 Intermediate Similarity NPC285410
0.8269 Intermediate Similarity NPC58942
0.8269 Intermediate Similarity NPC260149
0.8261 Intermediate Similarity NPC202051
0.8261 Intermediate Similarity NPC470921
0.8261 Intermediate Similarity NPC75417
0.8257 Intermediate Similarity NPC137917
0.8257 Intermediate Similarity NPC167383
0.8257 Intermediate Similarity NPC237503
0.8257 Intermediate Similarity NPC306746
0.8257 Intermediate Similarity NPC204407
0.8257 Intermediate Similarity NPC127853
0.8257 Intermediate Similarity NPC57362
0.8252 Intermediate Similarity NPC19376
0.8252 Intermediate Similarity NPC469528
0.8252 Intermediate Similarity NPC476318
0.8252 Intermediate Similarity NPC469369
0.8252 Intermediate Similarity NPC476327
0.8252 Intermediate Similarity NPC256227
0.8252 Intermediate Similarity NPC307282
0.8252 Intermediate Similarity NPC305464
0.8252 Intermediate Similarity NPC25848
0.825 Intermediate Similarity NPC471855
0.8246 Intermediate Similarity NPC6377
0.8246 Intermediate Similarity NPC472949
0.8246 Intermediate Similarity NPC475041
0.8246 Intermediate Similarity NPC473839

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC293850 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8435 Intermediate Similarity NPD8328 Phase 3
0.8333 Intermediate Similarity NPD6319 Approved
0.8288 Intermediate Similarity NPD4632 Approved
0.8198 Intermediate Similarity NPD8297 Approved
0.8148 Intermediate Similarity NPD6675 Approved
0.8148 Intermediate Similarity NPD7128 Approved
0.8148 Intermediate Similarity NPD6402 Approved
0.8148 Intermediate Similarity NPD5739 Approved
0.8091 Intermediate Similarity NPD8132 Clinical (unspecified phase)
0.8091 Intermediate Similarity NPD6372 Approved
0.8091 Intermediate Similarity NPD6373 Approved
0.8073 Intermediate Similarity NPD5701 Approved
0.8073 Intermediate Similarity NPD5697 Approved
0.807 Intermediate Similarity NPD8295 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD6899 Approved
0.8 Intermediate Similarity NPD5345 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD6881 Approved
0.8 Intermediate Similarity NPD7320 Approved
0.7946 Intermediate Similarity NPD6649 Approved
0.7946 Intermediate Similarity NPD6650 Approved
0.7928 Intermediate Similarity NPD6013 Approved
0.7928 Intermediate Similarity NPD6014 Approved
0.7928 Intermediate Similarity NPD6012 Approved
0.7913 Intermediate Similarity NPD6009 Approved
0.7909 Intermediate Similarity NPD6412 Phase 2
0.7885 Intermediate Similarity NPD7748 Approved
0.7876 Intermediate Similarity NPD6882 Approved
0.7864 Intermediate Similarity NPD7515 Phase 2
0.7857 Intermediate Similarity NPD6883 Approved
0.7857 Intermediate Similarity NPD7102 Approved
0.7857 Intermediate Similarity NPD7290 Approved
0.7838 Intermediate Similarity NPD6011 Approved
0.783 Intermediate Similarity NPD4755 Approved
0.783 Intermediate Similarity NPD7902 Approved
0.7797 Intermediate Similarity NPD5983 Phase 2
0.7788 Intermediate Similarity NPD6617 Approved
0.7788 Intermediate Similarity NPD8130 Phase 1
0.7788 Intermediate Similarity NPD6847 Approved
0.7788 Intermediate Similarity NPD6869 Approved
0.7768 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.775 Intermediate Similarity NPD7492 Approved
0.7712 Intermediate Similarity NPD6054 Approved
0.7712 Intermediate Similarity NPD6059 Approved
0.7705 Intermediate Similarity NPD7736 Approved
0.7699 Intermediate Similarity NPD4634 Approved
0.7686 Intermediate Similarity NPD7507 Approved
0.7686 Intermediate Similarity NPD6616 Approved
0.7685 Intermediate Similarity NPD4700 Approved
0.7685 Intermediate Similarity NPD4696 Approved
0.7685 Intermediate Similarity NPD5286 Approved
0.7685 Intermediate Similarity NPD5285 Approved
0.7679 Intermediate Similarity NPD6686 Approved
0.7667 Intermediate Similarity NPD7604 Phase 2
0.7658 Intermediate Similarity NPD6008 Approved
0.7647 Intermediate Similarity NPD6015 Approved
0.7647 Intermediate Similarity NPD3573 Approved
0.7647 Intermediate Similarity NPD6016 Approved
0.7632 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7623 Intermediate Similarity NPD8293 Discontinued
0.7623 Intermediate Similarity NPD7078 Approved
0.7583 Intermediate Similarity NPD5988 Approved
0.7583 Intermediate Similarity NPD6370 Approved
0.757 Intermediate Similarity NPD5222 Approved
0.757 Intermediate Similarity NPD4697 Phase 3
0.757 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.757 Intermediate Similarity NPD5221 Approved
0.7547 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7547 Intermediate Similarity NPD7900 Approved
0.7545 Intermediate Similarity NPD4633 Approved
0.7545 Intermediate Similarity NPD5226 Approved
0.7545 Intermediate Similarity NPD5224 Approved
0.7545 Intermediate Similarity NPD5211 Phase 2
0.7545 Intermediate Similarity NPD5225 Approved
0.7544 Intermediate Similarity NPD5955 Clinical (unspecified phase)
0.7541 Intermediate Similarity NPD6336 Discontinued
0.7521 Intermediate Similarity NPD6274 Approved
0.75 Intermediate Similarity NPD6083 Phase 2
0.75 Intermediate Similarity NPD6084 Phase 2
0.75 Intermediate Similarity NPD7319 Approved
0.75 Intermediate Similarity NPD5173 Approved
0.75 Intermediate Similarity NPD5328 Approved
0.75 Intermediate Similarity NPD4768 Approved
0.75 Intermediate Similarity NPD4767 Approved
0.7477 Intermediate Similarity NPD5174 Approved
0.7477 Intermediate Similarity NPD5175 Approved
0.7458 Intermediate Similarity NPD7115 Discovery
0.7455 Intermediate Similarity NPD5223 Approved
0.7453 Intermediate Similarity NPD6399 Phase 3
0.7431 Intermediate Similarity NPD7638 Approved
0.7411 Intermediate Similarity NPD5141 Approved
0.7379 Intermediate Similarity NPD3618 Phase 1
0.7368 Intermediate Similarity NPD4730 Approved
0.7368 Intermediate Similarity NPD4729 Approved
0.7364 Intermediate Similarity NPD7640 Approved
0.7364 Intermediate Similarity NPD7639 Approved
0.7358 Intermediate Similarity NPD6411 Approved
0.7358 Intermediate Similarity NPD6079 Approved
0.7355 Intermediate Similarity NPD6921 Approved
0.7333 Intermediate Similarity NPD7100 Approved
0.7333 Intermediate Similarity NPD7101 Approved
0.7321 Intermediate Similarity NPD4754 Approved
0.7315 Intermediate Similarity NPD5695 Phase 3
0.7311 Intermediate Similarity NPD6317 Approved
0.7281 Intermediate Similarity NPD5954 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD4225 Approved
0.7273 Intermediate Similarity NPD5696 Approved
0.7264 Intermediate Similarity NPD46 Approved
0.7264 Intermediate Similarity NPD6698 Approved
0.725 Intermediate Similarity NPD6335 Approved
0.725 Intermediate Similarity NPD6313 Approved
0.725 Intermediate Similarity NPD6314 Approved
0.7241 Intermediate Similarity NPD5247 Approved
0.7241 Intermediate Similarity NPD5251 Approved
0.7241 Intermediate Similarity NPD5249 Phase 3
0.7241 Intermediate Similarity NPD5250 Approved
0.7241 Intermediate Similarity NPD5248 Approved
0.7238 Intermediate Similarity NPD5737 Approved
0.7238 Intermediate Similarity NPD6672 Approved
0.7227 Intermediate Similarity NPD6868 Approved
0.7217 Intermediate Similarity NPD5128 Approved
0.7213 Intermediate Similarity NPD6908 Approved
0.7213 Intermediate Similarity NPD6909 Approved
0.719 Intermediate Similarity NPD7516 Approved
0.717 Intermediate Similarity NPD7285 Clinical (unspecified phase)
0.717 Intermediate Similarity NPD5764 Clinical (unspecified phase)
0.717 Intermediate Similarity NPD4753 Phase 2
0.717 Intermediate Similarity NPD6101 Approved
0.7157 Intermediate Similarity NPD3667 Approved
0.7143 Intermediate Similarity NPD6033 Approved
0.713 Intermediate Similarity NPD4202 Approved
0.7129 Intermediate Similarity NPD4695 Discontinued
0.7107 Intermediate Similarity NPD7328 Approved
0.7107 Intermediate Similarity NPD7327 Approved
0.7075 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7073 Intermediate Similarity NPD6291 Clinical (unspecified phase)
0.7073 Intermediate Similarity NPD8033 Approved
0.7059 Intermediate Similarity NPD8133 Approved
0.7048 Intermediate Similarity NPD5330 Approved
0.7048 Intermediate Similarity NPD6409 Approved
0.7048 Intermediate Similarity NPD7146 Approved
0.7048 Intermediate Similarity NPD6684 Approved
0.7048 Intermediate Similarity NPD7521 Approved
0.7048 Intermediate Similarity NPD7334 Approved
0.7034 Intermediate Similarity NPD5215 Approved
0.7034 Intermediate Similarity NPD5217 Approved
0.7034 Intermediate Similarity NPD5216 Approved
0.7019 Intermediate Similarity NPD3666 Approved
0.7019 Intermediate Similarity NPD3133 Approved
0.7019 Intermediate Similarity NPD4786 Approved
0.7019 Intermediate Similarity NPD3665 Phase 1
0.6992 Remote Similarity NPD8377 Approved
0.6992 Remote Similarity NPD8294 Approved
0.6977 Remote Similarity NPD7260 Phase 2
0.6972 Remote Similarity NPD5779 Approved
0.6972 Remote Similarity NPD5778 Approved
0.6949 Remote Similarity NPD5169 Approved
0.6949 Remote Similarity NPD5134 Clinical (unspecified phase)
0.6949 Remote Similarity NPD5135 Approved
0.6935 Remote Similarity NPD8296 Approved
0.6935 Remote Similarity NPD8378 Approved
0.6935 Remote Similarity NPD8517 Approved
0.6935 Remote Similarity NPD8335 Approved
0.6935 Remote Similarity NPD8515 Approved
0.6935 Remote Similarity NPD8380 Approved
0.6935 Remote Similarity NPD7503 Approved
0.6935 Remote Similarity NPD8516 Approved
0.6935 Remote Similarity NPD8379 Approved
0.6935 Remote Similarity NPD8513 Phase 3
0.6923 Remote Similarity NPD5168 Approved
0.6916 Remote Similarity NPD6903 Approved
0.6909 Remote Similarity NPD5282 Discontinued
0.6891 Remote Similarity NPD5127 Approved
0.6887 Remote Similarity NPD5279 Phase 3
0.6881 Remote Similarity NPD8035 Phase 2
0.6881 Remote Similarity NPD8034 Phase 2
0.6881 Remote Similarity NPD7983 Approved
0.6852 Remote Similarity NPD6080 Approved
0.6852 Remote Similarity NPD6904 Approved
0.6852 Remote Similarity NPD6673 Approved
0.6847 Remote Similarity NPD4629 Approved
0.6847 Remote Similarity NPD5210 Approved
0.6842 Remote Similarity NPD5344 Discontinued
0.6833 Remote Similarity NPD6053 Discontinued
0.6825 Remote Similarity NPD6067 Discontinued
0.6792 Remote Similarity NPD7520 Clinical (unspecified phase)
0.6783 Remote Similarity NPD7632 Discontinued
0.675 Remote Similarity NPD8413 Clinical (unspecified phase)
0.6727 Remote Similarity NPD5693 Phase 1
0.6721 Remote Similarity NPD5167 Approved
0.6699 Remote Similarity NPD7645 Phase 2
0.6698 Remote Similarity NPD3668 Phase 3
0.6698 Remote Similarity NPD4197 Approved
0.6696 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6334 Approved
0.6667 Remote Similarity NPD6845 Suspended
0.6667 Remote Similarity NPD6333 Approved
0.6636 Remote Similarity NPD5329 Approved
0.6636 Remote Similarity NPD5692 Phase 3
0.6602 Remote Similarity NPD3617 Approved
0.6577 Remote Similarity NPD5281 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data